🔬 Study corrects findings on mGlu3 receptor activation

A correction notice was issued regarding the study on mGlu3 receptor activation stimulating GDNF production in striatal neurons. This was published by Giuseppe Battaglia and colleagues on August 31, 2026. Issues were found in Figure 4B and Figure 6D, specifically regarding lane splicing and incorrect data representation. The authors provided revised figures and new densitometric analyses to correct these data presentation errors. Further underlying data is available from the corresponding author for review. 🔬

🤖 Robot Path Planning Correction Published

A correction was issued for the paper titled "Real environment obstacle circular edge expansion design robot path planning based on ant colony algorithm." The authors, Feng Li and colleagues, published this update on August 31, 2026. The correction specifically addresses an incorrect switching of figures 21 and 22 in the original submission. Figure 21 should actually be Figure 22, and vice-versa, though the captions are correct. This research relates to robot path planning security in real-world environments. The authors have provided the revised figures for reference. 🤖

⚠️ Clinical Trial Study Faces Data Availability Issue

An Expression of Concern was issued for a cross-sectional study on patient satisfaction in clinical trials. The study, concerning service quality, was published by the PLOS One Editors on August 31, 2026. The original raw data files were permanently destroyed on July 1, 2026, making them unavailable. This situation violates the PLOS Data Availability policy for the research. The updated article is available for download to view the correct version. 😟

🩺 New blood marker predicts stent restenosis risk

This study investigated the role of the NHHR in predicting in-stent restenosis (ISR) after drug-eluting stent (DES) implantation. Researchers at the First People’s Hospital of Kashgar collected data from 496 CHD patients between January 2019 and December 2024. Findings showed that NHHR and Total Cholesterol (TC) were independent risk factors for ISR. NHHR demonstrated superior predictive ability for ISR compared to TC and HDL-C. This suggests NHHR could be a key clinical indicator for risk stratification. 🩺

🎉 Forest Dept and ISRO win Onam celebrations

The Tourism department declared the winners of the 'Onam Tourism Week 2026' events, including the cultural procession finale. The Kerala Forest and Wildlife department won among state government departments in Kerala, while ISRO took first prize among central institutions. The Livestock Development Board secured the top spot among public-sector institutions during the festival. Thiruvananthapuram Corporation won the local self-government category, and NABARD won in the banking sector. These winners were announced on September 1, 2026, concluding the week-long celebrations.

🍎 Tim Cook steps down as Apple CEO after 15 years

Tim Cook has stepped down from his role as Apple CEO after 15 years of leading the company. He is handing over the reins to John Ternus, effective September 1st. Cook's farewell memo focused on thanking staff and Apple's culture, skipping product roadmaps and AI mentions. He clarified that he is not leaving Apple but is simply changing roles. Moving forward, Cook will serve as executive chairman of Apple's board. 🍎

🔬 AI in clinical trials market is set to boom 🚀

The AI in Clinical Trials Market was valued at USD 2.71 Billion in 2025 and is projected to hit USD 27.85 Billion by 2035. This massive growth is fueled by machine learning adoption and pressure to cut down trial costs for pharma and biotech firms. AI platforms are now used across the entire trial lifecycle, from design to safety monitoring, speeding up patient identification. In 2026, companies like Tempus AI and IQVIA expanded their platforms to meet this rising sponsor demand globally. Services is the fastest-growing offering segment with a CAGR of 28.80% from 2026–2035.

🤝 Vijay backs Rahul Gandhi for PM role

Tamil Nadu CM Vijay has chosen Rahul Gandhi as the INDIA bloc’s Prime Ministerial candidate, according to Congress leader Tharahai Cuthbert on Monday. This statement came after the TVK initially promoted Vijay for the top post, leading to alliance tensions. Cuthbert clarified that projections of Vijay becoming PM were not the official leadership stance. Both Vijay and Rahul Gandhi share a close connection, with Vijay inviting Gandhi to his swearing-in ceremony in Chennai. Congress asserted it is an autonomous party, not subordinate to the TVK. 🤝

🇮🇳 TN leader says Vijay backs Rahul Gandhi for PM role

Tamil Nadu Congress CLP leader Tharahai Cuthbert stated that Chief Minister C Joseph Vijay has supported Rahul Gandhi for the alliance's Prime Ministerial candidate. She clarified that there is no leadership rift between the ruling party and its ally, the TVK. The recent FIR against Rahul Gandhi in Haldwani, Uttarakhand, occurred on this context. Cuthbert suggested the FIR showed the BJP's political anxiety over Gandhi's public support. She confirmed that Vijay has chosen Rahul Gandhi as the PM candidate moving forward.

📉 Wall Street dips amid crude oil price surge

Wall Street experienced a dip as concerns about rising inflation resurfaced. This market movement is linked to the spiking prices of crude oil globally. Specifically, crude prices have shown significant increases recently. This situation is fueling renewed fears that central banks might need to hike interest rates. Investors are now closely watching how this trend progresses in the coming weeks. 📉

🚲 51 persons with disabilities get new three-wheelers

Fifty-one people with disabilities received free three-wheeler motor vehicles at the Visakhapatnam Collectorate on Monday. This state government initiative aims to boost independent living and self-reliance for the beneficiaries. Each vehicle is valued at approximately ₹1.02 lakh, according to legislator Vishnukumar Raju. Out of 79 applications received, 51 eligible individuals were selected from the 60 sanctioned vehicles for 2025-26. Officials confirmed plans to extend this benefit to more eligible persons in the future.